Prospective study. All patients who participated ELVIS study (clinical trials: 00875069) can be enrolled in SURIA.
Patients are contacted by telephone. Investigator delivery objective and honest information. If patients accepts the study, answers will be collected.
Collected data are: creatinine serum, two surveys (quality of life and activities of daily living), date of onset of renal replacement therapy.
